Found 12 articles for: "dyshidrotic eczema"
Palmoplantar Pustulosis: Therapy Update
August 2024 | Volume 23 | Issue 8 | Original Article | 626 | Copyright © August 2024
Palmoplantar pustulosis is a variant of psoriasis and a chronic skin disorder in which pruritic pustular eruptions appear on the palms and soles. It is thought to arise from a variety of genetic ...
Read MoreMycosis Fungoides Palmaris et Plantaris Mimicking "Dyshidrotic Eczema": A Case Report
July 2024 | Volume 23 | Issue 7 | Case Reports | 569 | Copyright © July 2024
Mycosis fungoides palmaris et plantaris (MFPP) is a rare variant of mycosis fungoides (MF), a type of cutaneous T-cell lymphoma. MFPP primarily affects the palms and soles of the feet and is ofte...
Read MoreThe Koebner Phenomenon in Bullous Pemphigoid
April 2024 | Volume 23 | Issue 4 | Case Reports | e100 | Copyright © April 2024
Beyond Wrinkles: A Comprehensive Review of the Uses of Botulinum Toxin
March 2024 | Volume 23 | Issue 3 | Original Article | 173 | Copyright © March 2024
Background: Botulinum neurotoxin (BoNT) exhibits inhibitory effects on the neuromuscular junction, and its use is well established in cosmetic dermatology. Our review aims to ana...
Read MoreManagement of Primary Focal Hyperhidrosis: An Algorithmic Approach
May 2021 | Volume 20 | Issue 5 | Original Article | 523 | Copyright © May 2021
Hyperhidrosis (HH) is defined as perspiration beyond the level required to maintain temperature regulation. HH affects nearly 4.8% of the population in the United States. It can have a great impact on...
Read MoreTwo Cases of Recalcitrant Dyshidrotic Eczema Treated With Dupilumab
May 2021 | Volume 20 | Issue 5 | Features | 558 | Copyright © May 2021
Dyshidrotic eczema, also known as dyshidrosis or pompholyx when involving larger bullae, is a chronic, relapsing palmoplantar...
Read MoreDupilumab in Dermatology: Potential for Uses Beyond Atopic Dermatitis
October 2019 | Volume 18 | Issue 10 | Features | 1053 | Copyright © October 2019
Dupilumab inhibits the interleukin-4 receptor subunit α and is FDA approved for treatment of moderate-to-severe atopic dermatitis. It is a relatively new drug, and whether it is efficacious for ...
Read MoreA Case of Complete Resolution of Severe Plantar Dyshidrotic Eczema With Dupilumab
February 2019 | Volume 18 | Issue 2 | Editorials | 211 | Copyright © February 2019
A 44-year-old woman with a history of asthma, hypercholesterolemia, and impaired glucose tolerance presented with severely painful and intensely pruritic plantar dermatitis for more than two years tha...
Read MoreDupilumab in the Treatment of Dyshidrosis: A Report of Two Cases of Dyshidrotic Eczema
March 2018 | Volume 17 | Issue 3 | Case Reports | 355 | Copyright © March 2018
Dyshidrotic eczema is a distinct entity, often considered on the spectrum of atopic dermatitis, that primarily effec...
Read MoreIntramuscular Steroids in the Treatment of Dermatologic Disease: A Systematic Review
March 2018 | Volume 17 | Issue 3 | Original Article | 323 | Copyright © March 2018
IMPORTANCE: Intramuscular (IM) steroids can be used to treat a wide variety of dermatologic diseases. Although seemingly effective and safe, this form of corticosteroid therapy may be underused amongs...
Read MoreIdentifying Signs of Tinea Pedis: A Key to Understanding Clinical Variables
October 2015 | Volume 14 | Issue 10 | Supplement Individual Articles | 42 | Copyright © October 2015
Tinea pedis is a frequently encountered dermatophytosis affecting the superficial skin of the feet, primarily of adults. The prevalence of tinea pedis has increased over the last several decades due t...
Read MoreTreatment of Mild-to-Moderate Chronic Hand Dermatitis With Clobetasol Propionate 0.05% EF Foam: Results From an Open-Label Study
December 2011 | Volume 10 | Issue 12 | Original Article | 1398 | Copyright © December 2011
Objective: To assess the safety and efficacy of clobetasol propionate 0.05% emulsion formulation (EF) foam in sub...
Read MoreMedia and other results for: "dyshidrotic eczema"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.